Company

Carmat SA

Headquarters: Velizy-Villacoublay, France

Employees: 139

CEO: Mr. Stephane Piat

Euronext: ALCAR

Market Cap

€6.4 Million

EUR as of Jan. 1, 2026

US$7.5 Million

Market Cap History

Carmat SA Categories

France Healthcare Medical Devices
France Healthcare France Medical Devices

Carmat SA market capitalization over time

Evolution of Carmat SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Carmat SA

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $216.15 B
Boston Scientific Corporation $140.40 B
Stryker $133.15 B
Medtronic $123.20 B
Edwards Lifesciences Corporation $50.10 B
Sector:
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Detailed Description

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It also develops orthotopic, bioprosthetic, self-regulating, pulsatile, and implantable systems, as well as power supply systems. The company was founded in 2008 and is based in Vélizy-Villacoublay, France.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Stocks & Indices

Carmat SA has the following listings and related stock indices.


Stock: Euronext: ALCAR

Stock: FSX: CXT

Details

Headquarters:

36, avenue de l'Europe

Immeuble l'Etendard

Velizy-Villacoublay, 78140

France

Phone: 33 1 39 45 64 50

Fax: 33 1 39 45 64 51